Governor John Carney (D) signed a bill in mid-June 2021 to let nurse practitioners and physician assistants recommend medical cannabis - signaling a potential boon to the MMJ population in the state.

Delaware lawmaker Rep. Ed Osienski (D) filed newly revised HB 305 in January 2022 with several changes from a previous version that passed a House committee but stalled ahead of a scheduled floor vote amid disagreements about equity provisions. The bill would allow adults 21 and older to purchase and possess up to one ounce of cannabis, but not provide a home-grow option.

There is no notable activity at this time.

Delaware is shaping up to be a prime acquisition market thanks to its middle-of-the-road population density and proximity to neighboring states with a large MSO presence. With a profitable revenue-to-license ratio and Columbia Care already building a presence, other MSOs will likely take action when they have excess resources to focus beyond their core strategic states.

Investors don't have much of a play here unless and until the state releases additional licenses.